Ibu Direkt Ratiopharm (Ibuprofen)

Ibu Direkt (ibuprofen) works within the prostaglandin pathway to relieve common discomforts and inflammatory conditions.

• Pain: provides analgesic relief for mild to moderate aches.
• Fever: reduces elevated body temperature.
• Inflammation: helps control swelling associated with musculoskeletal injuries or inflammatory disorders.

• Ibuprofen reversibly inhibits cyclooxygenase‑1 and cyclooxygenase‑2 (COX‑1, COX‑2) enzymes, which reduces the conversion of arachidonic acid to prostaglandins. Lower prostaglandin levels diminish inflammation, lower fever, and decrease the perception of pain at peripheral nerve endings and central pain pathways.

Adverse reactions may range from mild, transient symptoms to serious, potentially life‑threatening conditions.

Common Side Effects

• Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort.
• Headache or dizziness.
• Mild skin rash or itching.
• Elevated blood pressure.
• Diarrhoea.

Serious or Rare Side Effects

• Gastrointestinal bleeding or ulcer perforation.
• Severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome.
• Acute renal failure or worsening of chronic kidney disease.
• Hepatotoxicity with elevated liver enzymes.
• Thrombotic events in high‑risk cardiovascular patients.
• Severe thrombocytopenia or blood dyscrasias.

Before using Ibu Direkt, consider the following safety measures.

• Assess gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding.
• Use the lowest effective dose for the shortest duration needed.
• Avoid in individuals with known hypersensitivity to ibuprofen or other NSAIDs.
• Caution in renal or hepatic impairment: monitor function regularly.
• Pregnancy and breastfeeding: consult a healthcare professional before use.
• Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Ibuprofen can affect the activity of several other medicines; interactions are grouped by clinical significance.

Major Interactions (Avoid)

• Anticoagulants (e.g., warfarin): increased bleeding risk.
• Other NSAIDs or aspirin: heightened gastrointestinal toxicity.
• Corticosteroids: additive risk of ulceration.
• ACE inhibitors or ARBs: possible reduction in renal function.
• Lithium: elevated lithium serum concentrations.

Moderate Interactions (Monitor Closely)

• Diuretics: may reduce antihypertensive effect.
• Methotrexate: decreased clearance leading to toxicity.
• Antihypertensives: possible attenuation of blood pressure control.
• SSRIs: modest increase in bleeding tendency.
• Oral hypoglycemics: potential alteration of glucose control.